HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shepherd, G. Search for Related Content PubMed PubMed Citation Articles by Shepherd, G.

GREENE SHEPHERD, PHARM.D., DABAT, is Clinical Associate Professor, Medical College of Georgia, 1120 15th Street, CJ-1020, Augusta, GA 30912-2450 (jshepherd{at}mcg.edu).

Purpose. The toxic effects and treatment of ß-adrenergic blocker and calcium-channel blocker (CCB) overdose are reviewed. Summary. Overdoses with cardiovascular drugs are associated with significant morbidity and mortality. Beta-blockers and CCBs represent the most important classes of cardiovascular drugs. In overdose, ß-blockers and CCBs have similar presentation and treatment overlaps and are often refractory to standard resuscitation measures. The common feature of ß-blocker toxicity is excessive blockade of the ß-receptors resulting in bradycardia and hypotension. Poisoning by CCBs is characterized by cardiovascular toxicity with hypotension and conduction disturbances, including sinus bradycardia and varying degrees of atrioventricular block. Therapies include ß-agonists, glucagon, and phosphodiesterase inhibitors. However, in ß-blocker poisoning where symptomatic bradycardia and hypotension are present, high-dose glucagon is considered the first-line antidote. Traditionally, antidotes for CCB overdose have included calcium, glucagon, adrenergic drugs, and amrinone. For cases of CCB poisoning where cardiotoxicity is evident, first-line therapy is a combination of calcium and epinephrine; high-dose insulin with supplemental dextrose and potassium therapy (HDIDK) is reserved for refractory cases. Health-system pharmacists should be aware that when these drugs are used as antidotes, higher than normal dosing is needed. Conclusion. Poisoning by ß-blockers or CCBs usually produces hypotension and bradycardia, which may be refractory to standard resuscitation measures. For cases of ß-blocker poisoning where symptomatic bradycardia and hypotension are present, high-dose glucagon is considered the first-line antidote. For cases of CCB poisoning where cardiotoxicity is evident, a combination of calcium and epinephrine should be used initially, reserving HDIDK for refractory cases. Index terms: Amrinone; Antidotes; Calcium; Calcium antagonists; Combined therapy; Dextrose; Dosage; Epinephrine; Glucagon; Insulin; Phosphodiesterase inhibitors; Poisoning; Potassium; Sympatholytic agents; Sympathomimetic agents; Toxicity

 

This article has been cited by other articles:

				T. Varpula, J. Rapola, M. Sallisalmi, and J. Kurola Treatment of Serious Calcium Channel Blocker Overdose With Levosimendan, a Calcium Sensitizer Anesth. Analg., March 1, 2009; 108(3): 790 - 792. [Abstract] [Full Text] [PDF]

				Y. Kaplan, N Hocaoglu, K Oransay, S Kalkan, and Y Tuncok Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats Human and Experimental Toxicology, April 1, 2008; 27(4): 321 - 325. [Abstract] [PDF]

				P. M. Alapat and J. L. Zimmerman Toxicology in the Critical Care Unit Chest, April 1, 2008; 133(4): 1006 - 1013. [Abstract] [Full Text] [PDF]